Arvid Carlsson: An early pioneer in translational medicine

Science Translational Medicine

Volumn 1, Issue 2, 2009, Pages

  Andersen, Julie K ^a  

^a BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AWARDS AND PRIZES; HISTORY; HUMAN; MEDICAL RESEARCH; PARKINSON DISEASE; SWEDEN;

BIOMEDICAL RESEARCH; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; NOBEL PRIZE; PARKINSON DISEASE; SWEDEN;

EID: 77954665258     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3000149     Document Type: Short Survey

References (13)

1. S. H. Woolf, The meaning of translational research and why it matters. JAMA 299, 211-213 (2008).
2. A. Carlsson, M. Lindqvist, T. Magnusson, 3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists. Nature 180, 1200 (1957).
3. A. Carlsson, A half-century of neurotransmitter research: Impact on neurology and psychiatry, in Nobel Lectures, Physiology or Medicine 1996-2000, H. Jörnvall, Ed. (World Scientific Publishing, Singapore, 2003), pp. 303-322.
4. H. Ehringer, O. Hornykiewicz, Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system (transl. from German). Klin. Wochenschr. 38, 1236-1239 (1960).
5. W. Birkmayer, O. Hornykiewicz, The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia (transl. from German). Wien. Klin. Wochenschr. 73, 787-788 (1961).
6. A. Carlsson, Does dopamine have a role in schizophrenia? Biol. Psychiatry 13, 3-21 (1978).
7. A. Carlsson, T. Magnusson, T. H. Svensson, B. Waldeck, Effect of ethanol on the metabolism of brain catecholamines. Psychopharmacology (Berlin) 30, 27-36 (1973).
8. G. Grunder, A. Carlsson, D. F. Wong, Mechanism of new antipsychotic medications: Occupancy is not just antagonism. Arch. Gen. Psychiatry 60, 974-977 (2003).
9. J. Engel, A. Carlsson, Catecholamines and behavior. Curr. Dev. Psychopharmacol. 4, 1-32 (1977).
10. M. F. Piercey, J. T. Lum, W. E. Hoffmann, A. Carlsson, E. Ljung, K. Svensson, Antagonism of cocaine's pharmacological effects by the stimulant dopaminergic antagonists (+)-AJ76 and (+)-UH232. Brain Res. 588, 217-222 (1992).
11. A. Carlsson, Structural specificity for inhibition of [14C]-5-hydroxytryptamine uptake by cerebral slices. J. Pharm. Pharmacol. 22, 729-732 (1970).
12. J. Wålinder, A. Carlsson, R. Persson, 5-HT reuptake inhibitors plus tryptophan in endogenous depression. Acta Psychiatr. Scand. Suppl. 63, 179-190 (1981).
13. C. W. Olanow, M. B. Stern, K. Sethi, The scientific and clinical basis for the treatment of Parkinson disease. Neurology 72, S1-S136 (2009).